Calcitriol inhibits migration and invasion of RCC cells through suppressing Smad2/3-, STAT3 and β-catenin- mediated EMT.
Low vitamin D status is associated with progression in patients with renal cell carcinoma (RCC). This study found that vimentin, a mesenchymal marker, was accordingly upregulated, and E-cadherin, an epithelial marker, was downregulated in RCC patients with low vitamin D status. Thus, we investigated the effects of calcitriol, an active vitamin D3, on epithelial-mesenchymal transition (EMT) in RCC cells. RCC cells were treated by two models: model 1, ACHN, 786-O and CAKI-2 cells, three RCC cells, were incubated with either LPS (2.0 μg/ml) or TGF-β1 (10 ng/ml) in the presence or absence of calcitriol (200 nM); model 2, ACHN and CAKI-2 cells, two RCC cells, were incubated only with calcitriol (200 nM). Calcitriol inhibited migration and invasion not only in TGF-β1-stimulated but also TGF-β1-unstimulated RCC cells. Moreover, calcitriol suppressed E-cadherin downregulation and vimentin upregulation not only in TGF-β1-stimulated but also in TGF-β1-unstimulated ACHN and CAKI-2 cells. Calcitriol attenuated LPS-induced upregulation of MMP-2, MMP-7, MMP-9, MMP-26 and u-PA in ACHN cells. In addition, calcitriol blocked TGF-β1-induced nuclear translocation of ZEB1, Snail and Twist1 in ACHN and CAKI-2 cells. Mechanistically, calcitriol suppressed EMT through different signaling pathways: (1) calcitriol suppressed Smad2/3 phosphorylation through reinforcing physical interaction between vitamin D receptor (VDR) and Smad3 in TGF-β1-stimulated RCC cells; (2) calcitriol inhibited STAT3 activation in LPS-stimulated RCC cells; (3) calcitriol inhibited β-catenin/TCF-4 activation through promoting integration of VDR with β-catenin in TGF-β1-unstimulated RCC cells. Taken together, calcitriol inhibits migration and invasion of RCC cells partially through suppressing Smad2/3-, STAT3- and β-catenin- mediated EMT.